glp-1 receptor agonists cardiovascular benefits of glucagon-like peptide-1 A Comprehensive Review of the

[Google Scholar] 33.Update on Fdas Ongoing Evaluation of Reports of Suicidal Thoughts or Actions in Patients Taking a Certain Type of Medicines Approved for Type 2 Diabetes and Obesity

10.3892/ijmm.2018.3509 [DOI] [PubMed] [Google Scholar] 12.Moustafa PE, Abdelkader NF, El Awdan SA, El-Shabrawy OA, Zaki HF (2018) Liraglutide ameliorated peripheral neuropathy in diabetic rats: involvement of oxidative stress, inflammation and extracellular matrix remodeling

Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Peptide-1 Receptor Agonists

GLP-1 is a 30-amino-acid polypeptide synthesised by the L cells of the small intestine

Gallstones in obesity and weight loss

Side-by-side tolerability comparison The tolerability difference is significant and practical